Click on the link below to see the latest Letter of Announcement from EMVO related to the new release of the EMVO Gateway. EMVO LoA
The alarming growth in the number of falsified medicines in the European Union (EU) has been the basis for the development and implementation of the Falsified Medicines Directive. This involves introducing a European Medicines Verification System, which became operational in all EU countries on February 9th, 2019, following the entry into force of the Commission […]
Taking into consideration the dynamic nature of the National Medicines Verification System (NMVS) versions, meant to improve the overall system’s performance, the need to update the interfaces used by the End-Users (EU) to connect to the NMVS comes as a logical consequence. Thus, the V3 interface version used by the software providers to connect the […]
A new segment from the series of summaries related to the activity undertaken by our team, entitled: Spotlight on the OSMR Team, has our colleague: Adrian Zaharia, IT Consultant in the foreground. Adrian has been involved in the serialisation project since 2018, offering support on technical issues, and taking over the Technical and Operations Director […]
The latest Letter of Announcement from EMVO offers details about the successful deployment of EU Hub 1.9 to PROD. EMVO LoA
Please be informed that on 01.06.2021 and 02.06.2021, between 08:00 and 16:00, for approximately four hours, maintenance sessions are scheduled within the Test (IQE) Environment of the National Medicines Verification System (NMVS). The operations performed during this time interval will be uploaded to the NMVS test (IQE) environment at a later time.
Please find below the Letter of Announcement from EMVO on the upload of data to the European Medicines Verification System (EMVS). EMVO LoA
Related to the deployment date for PROD of EU Hub release 1.9, EMVO published the Letter of Announcement which can be found below. EMVO – LoA








